Glossary  HistCite Guide
Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes
Barouch DH, Kunstman J, Kuroda MJ, Schmitz JE, Santra S, Peyerl FW, Krivulka GR, Beaudry K, Lifton MA, Gorgone DA, Montefiori DC, Lewis MG, Wolinsky SM, Letvin NL
NATURE
415 (6869): 335-339 JAN 17 2002
and the citing papers
Potentially missed citations...
13 nodes have citations that may potentially refer to other nodes.

1 | 18 2002 DNA AND CELL BIOLOGY 21(9):689-695
Muthumani K; Hwang DS; Dayes NS; Kim JJ; Weiner DB
The HIV-1 accessory gene vpr can inhibit antigen-specific immune function

MUTHUMANI-K-2002-IN-PRESS-J-BIOL-CHEM

2 | 58 2003 AIDS 17(15):2149-2157
Currier JR; Dowling WE; Wasunna KM; Alam U; Masons CJ; Robb ML; Carr JK; McCutchan FE; Birx DL; Cox JH
Detection of high frequencies of HIV-1 cross-subtype reactive CD8 T lymphocytes in the peripheral blood of HIV-1-infected Kenyans

NOVITSKY V, 2002, J VIROL, V76, P5435 may refer to 32 NOVITSKY-V-2002-V76-I20-P10155-10168

3 | 73 2003 IMMUNOLOGY LETTERS 89(2-3):207-214
Majumder B; Gray B; McBurney S; Schaefer TM; Dentchev T; Mahalingam S; Reinhart TA; Ayyavoo V
Attenuated nef DNA vaccine construct induces cellular immune response: role in HIV-1 multiprotein vaccine

BAROUCH DH, 2002, VACCINE S4, V20, A66 may refer to 54 BAROUCH-DH-2002-V20--PA66-A68

4 | 74 2003 INTERNATIONAL IMMUNOLOGY 15(10):1161-1171
Haicheur N; Benchetrit F; Amessou M; Leclerc C; Falguieres T; Fayolle C; Bismuth E; Fridman WH; Johannes L; Tartour E
The B subunit of Shiga toxin coupled to full-size antigenic protein elicits humoral and cell-mediated immune responses associated with a T(h)1-dominant polarization

SENIOR K, 2002, LANCET, V359, P1216 may refer to 33 SENIOR-K-2002-V359-I9302-P235-235

5 | 82 2003 JOURNAL OF IMMUNOLOGY 171(10):5611-5623
Wilson CC; McKinney D; Anders M; MaWhinney S; Forster J; Crimi C; Southwood S; Sette A; Chesnut R; Newman MJ; Livingston BD
Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses to multiple conserved epitopes in HIV-1

NOVITSKY V, 2002, J VIROL, V76, P5435 may refer to 32 NOVITSKY-V-2002-V76-I20-P10155-10168

6 | 105 2003 JOURNAL OF VIROLOGY 77(20):10889-10899
McGettigan JP; Naper K; Orenstein J; Koser M; McKenna PM; Schnell MJ
Functional human immunodeficiency virus type 1 (HIV-1) gag-pol or HIV-1 Gag-Pol and Env expressed from a single rhabdovirus-based vaccine vector genome

BAROUCH DH, 2002, VACCINE S4, V20, A66 may refer to 54 BAROUCH-DH-2002-V20--PA66-A68

7 | 124 2003 VACCINE 21(27-30):4380-4389
van Harmelen JH; Shephard E; Thomas R; Hanke T; Williamson AL; Williamson C
Construction and characterisation of a candidate HIV-1 subtype C DNA vaccine for South Africa

NOVITSKY V, 2002, J VIROL, V76, P5435 may refer to 32 NOVITSKY-V-2002-V76-I20-P10155-10168

8 | 135 2004 CLINICAL MICROBIOLOGY REVIEWS 17(2):370-+
Giri M; Ugen KE; Weiner DB
DNA vaccines against human immunodeficiency virus type 1 in the past decade

BAROUCH DH, 2003, J VIROL, V77, P8729 may refer to 98 BAROUCH-DH-2003-V77-I13-P7367-7375

9 | 136 2004 CURRENT DRUG TARGETS 5(1):71-88
Stratov I; DeRose R; Purcell DFJ; Kent SJ
Vaccines and vaccine strategies against HIV

MCGETTIGAN JP, 2003, J VIROL, V77, P237 may refer to 105 MCGETTIGAN-JP-2003-V77-I20-P10889-10899

10 | 139 2004 IMMUNOLOGICAL REVIEWS 199(1):84-99
Calarota SA; Weiner DB
Enhancement of human immunodeficiency virus type 1-DNA vaccine potency through incorporation of T-helper 1 molecular adjuvants

BAROUCH DH, 2003, J VIROL, V77, P8729 may refer to 98 BAROUCH-DH-2003-V77-I13-P7367-7375

11 | 143 2004 JOURNAL OF EXPERIMENTAL MEDICINE 199(7):905-915
Draenert R; Le Gall S; Pfafferott KJ; Leslie AJ; Chetty P; Brander C; Holmes EC; Chang SC; Feeney ME; Addo MM; Ruiz LD; Ramduth D; Jeena P; Altfeld M; Thomas S; Tang TH; Verrill CL; Dixon C; Prado JG; Kiepiela P; Martinez-Picado J; Walker BD; Goulder PJR
Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection

YU XG, 2002, J VIROL, V76, P8990 may refer to 29 YU-XG-2002-V76-I17-P8690-8701

12 | 157 2004 NATURE MEDICINE 10(3):282-289
Leslie AJ; Pfafferott KJ; Chetty P; Draenert R; Addo MM; Feeney M; Tang Y; Holmes EC; Allen T; Prado JG; Altfeld M; Brander C; Dixon C; Ramduth D; Jeena P; Thomas SA; St John A; Roach TA; Kupfer B; Luzzi G; Edwards A; Taylor G; Lyall H; Tudor-Williams G; Novelli V; Martinez-Picado J; Kiepiela P; Walker BD; Goulder PJR
HIV evolution: CTL escape mutation and reversion after transmission

NOVITSKY V, 2002, J VIROL, V76, P5435 may refer to 32 NOVITSKY-V-2002-V76-I20-P10155-10168

13 | 158 2004 NATURE REVIEWS GENETICS 5(1):52-61
Rambaut A; Posada D; Crandall KA; Holmes EC
The causes and consequences of HIV evolution

NAJERA R, 2002, AIDS S4, V16, S3 may refer to 1 NAJERA-R-2002-V16--PS3-S16